Reaction Details Report a problem with these data
Target
Melanocortin receptor 4
Ligand
BDBM323236
Substrate
n/a
Meas. Tech.
Transactivation Assay
EC50
100.0±n/a nM
Citation
 Bouix-Peter, C; Suzuki, I; Rodeville, N; Mauvais, P; Pascal, J Oxoazetidine derivatives, process for the preparation thereof and use thereof in human medicine and in cosmetics US Patent  US9630949 Publication Date 4/25/2017 
Target
Name:
Melanocortin receptor 4
Synonyms:
MC4-R | MC4R | MC4R_HUMAN | Melanocortin MC4 | Melanocortin receptor 4 (MC-4) | Melanocortin receptor 4 (MC4-R) | Melanocortin receptor 4 (MC4R)
Type:
Enzyme
Mol. Mass.:
36949.50
Organism:
Homo sapiens (Human)
Description:
P32245
Residue:
332
Sequence:
MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY
  
Inhibitor
Name:
BDBM323236
Synonyms:
N-[2-(3-butoxy-3-o-tolylazetidin-1-yl)-1-(2,4-dichlorobenzyl)-2-oxoethyl]-3-(1H-imidazol-4-yl)hexylamide | US9630949, 65
Type:
Small organic molecule
Emp. Form.:
C32H41Cl2N4O2
Mol. Mass.:
584.6
SMILES:
CCCCOC1(CN(C1)C(=O)C(Cc1ccc(Cl)cc1Cl)[N-]CCC(CCC)c1c[nH]cn1)c1ccccc1C
Structure:
Search PDB for entries with ligand similarity: